Cargando…

Central nervous system post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation: The Nagasaki transplant group experience

A 17-year-old male received allogeneic transplantation for acute lymphoblastic leukemia, and presented with generalized seizures due to a solitary brain lesion with massive necrosis on day +621. Epstein–Barr virus (EBV) DNA copies were below the cut-off value in plasma. Stereotactic biopsy of the ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sakamoto, Hikaru, Itonaga, Hidehiro, Taguchi, Jun, Kato, Takeharu, Sawayama, Yasushi, Hayashi, Tomayoshi, Baba, Shiro, Moriuchi, Masako, Ohshima, Koichi, Yoshida, Shinichiro, Moriuchi, Yukiyoshi, Miyazaki, Yasushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484211/ https://www.ncbi.nlm.nih.gov/pubmed/31049285 http://dx.doi.org/10.1016/j.lrr.2019.04.003

Ejemplares similares

High-dose Chemotherapy with Stem Cell Rescue Provided Durable Remission for Classical Hodgkin Lymphoma-type Post-transplant Lymphoproliferative Disorder after Unrelated Cord Blood Transplantation: A Case Report and Review of the Literature
por: Itonaga, Hidehiro, et al.
Publicado: (2017)

Successful outcome of second allogeneic bone marrow transplantation for blastic plasmacytoid dendritic cell neoplasm with MYC locus rearrangement
por: Kato, Takeharu, et al.
Publicado: (2019)

No clear survival benefit of azacitidine for lower‐risk myelodysplastic syndromes: A retrospective study of Nagasaki
por: Toriyama, Eo, et al.
Publicado: (2020)

Primary Oral Mucormycosis Due to Rhizopus microsporus after Allogeneic Stem Cell Transplantation
por: Sakamoto, Hikaru, et al.
Publicado: (2018)

Genome analysis of myelodysplastic syndromes among atomic bomb survivors in Nagasaki
por: Taguchi, Masataka, et al.
Publicado: (2020)

Efficacy and Cardiovascular Adverse Events of Long-term Treatment with Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: A Report from the Nagasaki CML Study Group
por: Chiwata, Masahiko, et al.
Publicado: (2021)

Clinical features and prognosis of patients with myelodysplastic syndromes who were exposed to atomic bomb radiation in Nagasaki
por: Matsuo, Masatoshi, et al.
Publicado: (2016)

Secondary Pulmonary Alveolar Proteinosis Following Treatment with Azacitidine for Myelodysplastic Syndrome
por: Hashimoto, Miki, et al.
Publicado: (2019)

Frequency of HTLV-1 seroconversion between pregnancies in Nagasaki, Japan, 2011–2018
por: Komatsu, Nahoko, et al.
Publicado: (2022)

Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic Hematopoietic Stem Cell Transplantation: Biology and Treatment Options
por: Clerico, Michele, et al.
Publicado: (2022)

Allogeneic hematopoietic stem cell transplantation in patients with advanced indolent lymphoproliferative disorders
por: Fonseca-Hial, Ana Marcela Rojas, et al.
Publicado: (2016)

Post-transplant Lymphoproliferative Disorder Following Cardiac Transplantation
por: Asleh, Rabea, et al.
Publicado: (2022)

Management of Epstein–Barr virus-related post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation
por: Liu, Li, et al.
Publicado: (2020)

Hangeshashinto for prevention of oral mucositis in patients undergoing hematopoietic stem cell transplantation: a randomized phase II study
por: Yoshimatsu, Masako, et al.
Publicado: (2023)

Post-transplant lymphoproliferative disease
por: Dharnidharka, Vikas R., et al.
Publicado: (2009)

Development of a modified prognostic index for patients with aggressive adult T-cell leukemia-lymphoma aged 70 years or younger: possible risk-adapted management strategies including allogeneic transplantation
por: Fuji, Shigeo, et al.
Publicado: (2017)

Post-transplant lymphoproliferative disease after pediatric kidney transplant
por: Fulchiero, Rosanna, et al.
Publicado: (2022)

Membranous Nephropathy with Crescent after Hematopoietic Cell Transplantation
por: Kitamura, Mineaki, et al.
Publicado: (2018)

Primary CNS post-transplant lymphoproliferative disorder following haploidentical HSCT using post-transplant high-dose cyclophosphamide
por: Toyosaki, Masako, et al.
Publicado: (2018)

Ocular post-transplant lymphoproliferative disorder
por: Chen, Yun-Wen, et al.
Publicado: (2015)

Post-transplant lymphoproliferative disease of the larynx
por: Vandjelovic, Nathan D, et al.
Publicado: (2019)

Management of post-transplant lymphoproliferative disorders
por: Dierickx, Daan, et al.
Publicado: (2019)

Blastic Epstein-Barr virus associated post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation for severe aplastic anemia
por: Hotta, Masaaki, et al.
Publicado: (2018)

Two Cases of Post Transplant Lymphoproliferative Disorder in Lung Transplant Recipients
por: Chang, Yoon Soo, et al.
Publicado: (2004)

Post-transplant lymphoproliferative disorder of the bladder in a lung transplant recipient
por: Grewal, Harpreet Singh, et al.
Publicado: (2018)

Occurrence of Post-Transplant Lymphoproliferative Disease in a Renal Transplant Patient
por: Ali, Sofiah, et al.
Publicado: (2021)

Graft-versus-MDS effect after unrelated cord blood transplantation: a retrospective analysis of 752 patients registered at the Japanese Data Center for Hematopoietic Cell Transplantation
por: Ishiyama, Ken, et al.
Publicado: (2019)

Outcome of Rituximab-Based Treatment for Post-Transplant Lymphoproliferative Disorder After Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience
por: Zhu, Cheng-ying, et al.
Publicado: (2019)

Case Report: Successful Chimeric Antigen Receptor T Cell Therapy in Haploidentical-Allogeneic Stem Cell Transplant Patients With Post-Transplant Lymphoproliferative Disorder
por: Yan, Nan, et al.
Publicado: (2021)

Acute Exacerbation of Pleuroparenchymal Fibroelastosis Secondary to Allogenic Hematopoietic Stem Cell Transplantation
por: Murakami, Yasushi, et al.
Publicado: (2020)

Clinical Characteristics and Outcomes of Posttransplant Lymphoproliferative Disorders Following Allogeneic Hematopoietic Stem Cell Transplantation in Korea
por: Park, Sun Hee, et al.
Publicado: (2006)

POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD) IN RENAL TRANSPLANT PATIENTS WITH COVID-19
por: MAHONEY, IAN, et al.
Publicado: (2022)

Posttransplant Lymphoproliferative Disease after Lung Transplantation
por: Neuringer, Isabel P.
Publicado: (2013)

Post-transplantation lymphoproliferative disorder with gastrointestinal involvement
por: Inayat, Faisal, et al.
Publicado: (2018)

Post‐transplant Lymphoproliferative Disorders After Liver Transplantation: A Retrospective Cohort Study Including 1954 Transplants
por: Tajima, Tetsuya, et al.
Publicado: (2021)

CAR-T after Stem Cell Transplantation in B-Cell Lymphoproliferative Disorders: Are They Really Autologous or Allogenic Cell Therapies?
por: Bartoló-Ibars, Ariadna, et al.
Publicado: (2021)

Rituximab is Indispensable for Pediatric Heart Transplant Recipients Developing Post Transplant Lymphoproliferative Disorders
por: Karbasi-Afshar, R, et al.
Publicado: (2013)

Dermoscopic features of cutaneous post-transplant lymphoproliferative disorder in a renal transplant recipient
por: Wang, Hua Xian Elizabeth, et al.
Publicado: (2022)

Surgical technique for allogeneic uterus transplantation in macaques
por: Obara, Hideaki, et al.
Publicado: (2016)

Allogeneic Hair Transplant in a Kidney Transplant Recipient
por: Popescu, Felix Mircea, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b65o9046lh5ok04dq1gtfvthl9